Literature DB >> 3622497

In vitro evaluation of the new paulomycin antibiotic paldimycin.

G M Eliopoulos, E Reiszner, R C Moellering.   

Abstract

The comparative in vitro activity of paldimycin, a new antibiotic, was evaluated against 215 gram-positive bacteria. Activity of the compound was greater in nutrient agar of pH 6.8 than in Mueller-Hinton agar. All strains of staphylococci, streptococci, enterococci and Listeria monocytogenes were inhibited at concentrations less than or equal to 2 micrograms/ml. Activity of the new drug was generally comparable to that of vancomycin.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3622497     DOI： 10.1007/bf02017620

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


  3 in total

1.  In-vitro activity of Sch 29482 in comparison with other oral antibiotics.

Authors:  G M Eliopoulos; A Gardella; R C Moellering
Journal:  J Antimicrob Chemother       Date:  1982-02       Impact factor: 5.790

2.  In vitro susceptibility of gram-positive cocci to paldimycin.

Authors:  D J Pohlod; L D Saravolatz; M M Somerville
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

3.  Paulomycins A and B. Isolation and characterization.

Authors:  A D Argoudelis; T A Brinkley; T F Brodasky; J A Buege; H F Meyer; S A Mizsak
Journal:  J Antibiot (Tokyo)       Date:  1982-03       Impact factor: 2.649
  3 in total
  2 in total

1.  New insights into paulomycin biosynthesis pathway in Streptomyces albus J1074 and generation of novel derivatives by combinatorial biosynthesis.

Authors:  Aránzazu González; Miriam Rodríguez; Alfredo F Braña; Carmen Méndez; José A Salas; Carlos Olano
Journal:  Microb Cell Fact       Date:  2016-03-21       Impact factor: 5.328

2.  Novel Bioactive Paulomycin Derivatives Produced by Streptomyces albus J1074.

Authors:  Jorge Fernández-De la Hoz; Carmen Méndez; José A Salas; Carlos Olano
Journal:  Molecules       Date:  2017-10-18       Impact factor: 4.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.